Azenta, Inc. $AZTA Shares Bought by Royal Bank of Canada

Royal Bank of Canada raised its holdings in Azenta, Inc. (NASDAQ:AZTA) by 0.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 574,164 shares of the company’s stock after acquiring an additional 721 shares during the period. Royal Bank of Canada owned approximately 1.26% of Azenta worth $19,888,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Deutsche Bank AG increased its holdings in shares of Azenta by 28.5% during the 4th quarter. Deutsche Bank AG now owns 4,199 shares of the company’s stock worth $210,000 after buying an additional 931 shares during the last quarter. SG Americas Securities LLC increased its holdings in shares of Azenta by 90.6% during the 1st quarter. SG Americas Securities LLC now owns 30,972 shares of the company’s stock worth $1,073,000 after buying an additional 14,719 shares during the last quarter. Principal Financial Group Inc. increased its holdings in shares of Azenta by 2.4% during the 1st quarter. Principal Financial Group Inc. now owns 226,491 shares of the company’s stock worth $7,846,000 after buying an additional 5,408 shares during the last quarter. Millennium Management LLC increased its holdings in shares of Azenta by 19.8% during the 4th quarter. Millennium Management LLC now owns 108,175 shares of the company’s stock worth $5,409,000 after buying an additional 17,899 shares during the last quarter. Finally, Nuveen LLC acquired a new stake in shares of Azenta during the 1st quarter worth approximately $11,604,000. Institutional investors and hedge funds own 99.08% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Stephens assumed coverage on shares of Azenta in a report on Tuesday, July 22nd. They set an “equal weight” rating and a $35.00 price target for the company. Evercore ISI set a $33.00 price target on shares of Azenta and gave the stock an “in-line” rating in a report on Tuesday, August 5th. Finally, Raymond James Financial upgraded shares of Azenta from a “market perform” rating to an “outperform” rating and set a $35.00 target price for the company in a report on Wednesday, August 6th. Two research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, Azenta currently has a consensus rating of “Hold” and a consensus target price of $35.75.

Azenta Stock Down 2.7%

NASDAQ:AZTA opened at $29.47 on Tuesday. The company has a fifty day simple moving average of $31.32 and a two-hundred day simple moving average of $31.34. The company has a market cap of $1.35 billion, a price-to-earnings ratio of -12.18 and a beta of 1.65. Azenta, Inc. has a 52 week low of $23.91 and a 52 week high of $55.63.

Azenta (NASDAQ:AZTA) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.13 by $0.06. The business had revenue of $143.94 million during the quarter, compared to the consensus estimate of $149.64 million. Azenta had a negative net margin of 18.45% and a positive return on equity of 1.35%. The company’s quarterly revenue was up .0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.14 earnings per share. On average, analysts expect that Azenta, Inc. will post 0.53 EPS for the current year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.